Investigational Drug Details
| Drug ID: | D553 |
| Drug Name: | TQA3526 |
| Synonyms: | TQA-3526 |
| Type: | Chemical drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | -- |
| CasNo: | -- |
| Repositioning for NAFLD: | No |
| SMILES: | -- |
| InChiKey: | -- |
| Molecular Weight: | -- |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | Farnesoid X-activated receptor agonist |
| Therapeutic Category: | Hepatoprotectants |
| Clinical Trial Progress: | Phase 1 on-going (ChiCTR1800019570) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0487 | ChiCTR1800019570 | Phase 1 | Not Recruiting | No Results Available | 18/11/2018 | 19 November 2018 | Details |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|